Headquartered in Toronto, Canada, Mindset Pharma Inc. is dedicated to the development and commercialization of psychedelic medications for the treatment of neurological and psychiatric conditions within Canada. A key component of their pipeline involves advancing MSP-1014, a specific psychedelic drug candidate.